Want to add the VA angle for veterans not on Tricare:
The VA added semaglutide (Ozempic) to their national formulary in 2024 for T2D. For obesity specifically, it's available through the VA MOVE! Weight Management Program, but availability varies wildly by VAMC. My local VA in Phoenix has been prescribing it through MOVE! since mid-2025 — copay is $0 for service-connected conditions, $15 for non-service-connected if you're in Priority Group 1-6.
Tirzepatide (Mounjaro) is available at some VAMCs through individual VISN formulary decisions, but it's not national formulary yet.
If you're a veteran with service-connected obesity-related conditions (sleep apnea, diabetes, MSK injuries causing limited mobility), push for the service-connection angle. It opens doors.